Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)

Area of Science:

• Immunology
• Vaccinology
• Clinical Medicine

Background:

• Primary antibody deficiencies, including common variable immunodeficiency (CVID), impair vaccine responses.
• CVID is the most prevalent and clinically significant antibody deficiency.
• Patients with CVID typically exhibit an inadequate response to vaccinations.

Purpose of the Study:

• To review current knowledge on humoral and cellular immune responses to influenza vaccination in CVID patients.
• To assess the efficacy and safety of influenza vaccines in individuals with CVID.

Main Methods:

• Literature review of studies on influenza vaccine response in CVID patients.
• Analysis of humoral (antibody) and cellular (T-cell) immune responses.

Main Results:

• Influenza vaccination in CVID patients results in an impaired humoral immune response.
• Cellular immune responses show mixed results, with some studies indicating similarity to healthy individuals.
• Evidence suggests a beneficial effect of influenza vaccination in this population.

Conclusions:

• Despite an impaired humoral response, influenza vaccination is beneficial for CVID patients.
• Annual influenza vaccination is recommended for CVID patients and their close contacts.
• Further research may clarify optimal vaccination strategies for CVID.